LPL Financial LLC grew its stake in Delek US Holdings, Inc. (NYSE:DK - Free Report) by 64.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 66,085 shares of the oil and gas company's stock after acquiring an additional 25,937 shares during the period. LPL Financial LLC owned 0.10% of Delek US worth $1,223,000 at the end of the most recent reporting period.
Several other hedge funds have also recently modified their holdings of DK. KBC Group NV boosted its stake in shares of Delek US by 66.3% in the fourth quarter. KBC Group NV now owns 3,859 shares of the oil and gas company's stock worth $71,000 after buying an additional 1,538 shares during the last quarter. ARS Investment Partners LLC acquired a new position in Delek US in the fourth quarter valued at about $185,000. Abel Hall LLC acquired a new position in Delek US in the fourth quarter valued at about $196,000. Van ECK Associates Corp lifted its position in shares of Delek US by 17.8% during the fourth quarter. Van ECK Associates Corp now owns 14,111 shares of the oil and gas company's stock worth $261,000 after purchasing an additional 2,134 shares in the last quarter. Finally, Equitable Trust Co. purchased a new stake in shares of Delek US during the fourth quarter worth approximately $341,000. Hedge funds and other institutional investors own 97.01% of the company's stock.
Insider Activity at Delek US
In related news, CFO Mark Wayne Hobbs acquired 2,800 shares of the business's stock in a transaction dated Tuesday, March 11th. The shares were bought at an average price of $13.70 per share, with a total value of $38,360.00. Following the transaction, the chief financial officer now directly owns 49,138 shares of the company's stock, valued at $673,190.60. This trade represents a 6.04 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders purchased 5,055 shares of company stock worth $70,787 over the last three months. Company insiders own 1.80% of the company's stock.
Analyst Upgrades and Downgrades
DK has been the subject of several research analyst reports. Piper Sandler decreased their price objective on Delek US from $18.00 to $17.00 and set a "neutral" rating for the company in a report on Friday, March 7th. Wolfe Research upgraded shares of Delek US from an "underperform" rating to a "peer perform" rating in a research report on Friday, January 3rd. Wells Fargo & Company lowered their target price on shares of Delek US from $16.00 to $11.00 and set an "underweight" rating on the stock in a research report on Wednesday, April 16th. Mizuho reduced their price objective on shares of Delek US from $25.00 to $22.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 9th. Finally, UBS Group dropped their price objective on shares of Delek US from $21.00 to $13.25 and set a "neutral" rating for the company in a research report on Wednesday, April 9th. Five analysts have rated the stock with a sell rating, six have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $17.48.
Get Our Latest Analysis on Delek US
Delek US Stock Up 1.0 %
DK traded up $0.13 during trading hours on Wednesday, hitting $13.16. 83,465 shares of the company's stock were exchanged, compared to its average volume of 1,211,330. The company has a quick ratio of 0.67, a current ratio of 1.04 and a debt-to-equity ratio of 3.18. The stock's 50-day moving average is $14.87 and its two-hundred day moving average is $17.01. Delek US Holdings, Inc. has a 1-year low of $11.03 and a 1-year high of $29.81. The stock has a market cap of $822.67 million, a price-to-earnings ratio of -2.71 and a beta of 1.04.
Delek US (NYSE:DK - Get Free Report) last issued its quarterly earnings results on Tuesday, February 25th. The oil and gas company reported ($2.54) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.53) by ($1.01). Delek US had a negative net margin of 2.27% and a negative return on equity of 28.21%. The company had revenue of $2.37 billion during the quarter, compared to the consensus estimate of $2.58 billion. During the same quarter last year, the firm posted ($1.46) earnings per share. The company's quarterly revenue was down 39.8% on a year-over-year basis. Sell-side analysts predict that Delek US Holdings, Inc. will post -5.5 earnings per share for the current fiscal year.
Delek US Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Monday, March 10th. Investors of record on Monday, March 3rd were issued a $0.255 dividend. The ex-dividend date was Monday, March 3rd. This represents a $1.02 dividend on an annualized basis and a yield of 7.75%. Delek US's payout ratio is -11.54%.
Delek US Company Profile
(
Free Report)
Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.
Featured Articles

Before you consider Delek US, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delek US wasn't on the list.
While Delek US currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.